Health Minister Greg Hunt said on Monday, Australia's Delta outbreak appears to have levelled off, with more than half the country in extended lockdowns and vaccination rates starting to approach national targets, Hunt said 80% of Australians will have had their first COVID-19 jabs this week,
On Thursday, Merck & Co (MRK.N) said it would buy Acceleron Pharma Inc (XLRN.O) for about $11.5 billion, broadening its portfolio beyond aging cancer drug Keytruda with potential treatments that could bring in fresh revenue. The deal gives Merck access to Acceleron's rare disease drug candidate, sotatercept, which the company